Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients
Mei Meng(Shanghai Ninth People's Hospital), Dechang Chen(Ruijin Hospital), Lidi Zhang(Shanghai Jiao Tong University), Yan Xu(Hebei Agricultural University), Xuan Dong(The Ohio State University), Jieming Qu(Shanghai Jiao Tong University), Djillali Annane(Hôpital Raymond-Poincaré), Hangxiang Du(Shanghai Jiao Tong University), Yunxin Deng(Shanghai Jiao Tong University), Jiao Liu(Sun Yat-sen University), Tao Wang(Shanghai Jiao Tong University), Limin Chen(Jiangnan University), Ranran Li(Shanghai Jiao Tong University), Sisi Huang(Shanghai Jiao Tong University), Sheng Zhang(Shanghai East Hospital), Yizhu Chen(Shanghai Jiao Tong University), Wenzhe Li(Shantou University), Yanxia Huang(Shanghai Jiao Tong University), Yongan Liu(Shanghai Jiao Tong University), Zhenliang Wen(Shanghai Jiao Tong University)
Cited by 21
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k